AI Insight
Researchers at Rice University have developed a method to protect transplanted insulin-producing cells from immune system rejection by engineering them to produce a protective "halo" of interleukin-10 (IL-10). This approach creates a localized immunosuppressive environment around pancreatic beta cells, potentially preventing the host immune system from attacking the transplanted cells. The technique uses the cells themselves as living factories to continuously produce the protective protein in their immediate vicinity.
Why it matters
This development could significantly improve outcomes for type 1 diabetes patients who receive beta cell transplants, potentially eliminating or reducing the need for systemic immunosuppressive drugs that have serious side effects. The localized immune protection strategy may also be applicable to other types of cell transplantation therapies.
Understand the Science
A protein known as interleukin 10 (IL-10) is the lynchpin of a new method to protect transplanted cells from host immune system attacks. Rice University researchers engineered a living factory to produce a localized biochemical halo of IL-10 to suppress immune rejection of pancreatic beta cells.
Source: Bioengineers develop biochemical halo to cloak insulin-producing cells from body defenses